The NCPA Outstanding Adherence Practitioner Award recognizes an independent community pharmacist who demonstrates a continuous commitment to patient adherence services.
The recipient of this year’s NCPA Prescription Drug Safety Award has worked for years to ensure that those who need naloxone have access to it.
Upsher-Smith Laboratories was honored Sunday with the National Community Pharmacists Association 2015 Corporate Recognition Award.
The American Pharmacists Association announced Friday that its fight toward provider status for pharmacists had reached a big milestone.
The drug can now be used on patients whose non-small cell lung cancer metastasized while undergoing platinum-based chemotherapy or afte
The company announced Friday that it had received certification to process Europay, MasterCard and Visa credit card purchases from Heartland Payment Systems.
The Boston Globe reports that if there were a measles outbreak, one-in-eight children — particularly young children — would contract the virus, based on research from Emory University, and immunization is the most critical way to prevent that. “If we do start to see immunization levels dip down a little bit and we see those dips sustained, we could start to lose that overall population level immunity,” study author Robert Bednarczyk said. “And if measles get introduced, we may start seeing larger and more severe outbreaks.” (Boston Globe)
The distinction recognizes CVS/specialty's commitment to helping people with arthritis and joint pain, and builds on the longstanding relationship between the two organizations. CVS/pharmacy is currently the exclusive retail drug store partner of the Arthritis Foundation.
The New York Times outlines the controversy surrounding the recent FDA approval of Oxycontin in children. “Just because OxyContin has been abused or prescribed inappropriately doesn’t mean we should deprive the children who need the drug,” Kathleen Neville, pediatric oncologist at Arkansas Children's Hospital told The New York Times, adding it is “our obligation to have the best level of evidence for its use in children.” (The New York Times)